SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis

doi:10.3748/wjg.v21.i27.8398

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9284)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-8) series.

Item

Count

PDF

562

WORD

297

HTML

4703

Figures (1-5)

306

Tables (1-8)

292

Sum=6160

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1126

Download

1998

Sum=3124

Jul 21, 2015 (publication date) through Mar 16, 2025

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Jul 21, 2015; 21(27): 8398-8407
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8398

Table 3 Patient and tumor characteristics

Clinicopathological factors		n (%)
Gender	Male	226 (54.2)
	Female	191 (45.8)
Age (yr)	≤ 60	223 (53.5)
	> 60	194 (46.5)
	Median	60
Gastrointestinal bleeding	No	315 (75.5)
	Yes	102 (24.5)
Primary tumor site	Stomach	229 (54.9)
	Small bowel	123 (29.5)
	Colon	21 (5.0)
	Others	44 (10.6)
Predominant cell type	Spindle	271 (65.0)
	Epithelioid	54 (12.9)
	Mixed	92 (22.1)
Primary tumor size (cm)	0-5	202 (48.4)
	5.1-10	138 (33.1)
	> 10	77 (18.5)
	Median	5.5
Mitotic index (per 50 HPFs)	0-5	309 (74.1)
	6-10	60 (14.4)
	> 10	48 (11.5)
NIH stage	Very low risk	33 (7.9)
	Low risk	154 (36.5)
	Intermediate risk	67 (16.1)
	High risk	163 (39.1)
Recurrence	No	331 (79.4)
	Yes	71 (17.0)
	Insufficient data	15 (3.6)
Death from illness	No	376 (90.2)
	Yes	26 (6.2)
	Insufficient data	15 (3.6)

Citation: Wang CJ, Zhang ZZ, Xu J, Wang M, Zhao WY, Tu L, Zhuang C, Liu Q, Shen YY, Cao H, Zhang ZG. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis. World J Gastroenterol 2015; 21(27): 8398-8407
URL: https://www.wjgnet.com/1007-9327/full/v21/i27/8398.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i27.8398